| 영문 | endocrine gland | 한글 | 내분비샘 |
|---|---|---|---|
| 설명 | 신체의 내부로 분비가 되어서 다른 세포의 기능이나 활성의 변화를 일으키는 물질인 호르몬을 분비하는 곳을 이르는 말이다. 대표적인 내분비샘은 갑상샘, 부갑상샘, 부신, 이자, 뇌하수체, 난소, 고환, 솔방울샘, 가슴샘 등이다. 마지막에 나오는 2개의 기관은 내분비 기능을 하는 것으로 생각이 되지만 확실히 그것이 무슨 기능을 하는 지에 대해선 아직까지 정확하게 밝혀지지 않고 있다.  |
||
| MEN | Multiple Endocrine Neoplasia ; AD Trait 1. MEN Type I(= Wermer Syndro... |
|---|---|
| AZO | [indicates presence of the group -N:N-] |
| XO | presence of only one sex chromosome; xanthine oxidase |
| MEDAC Syndrome | Multiple-Endocrine Deficiency Autoimmune-Candidiasis |
| AEP | acute edematous pancreatitis; artificial endocrine pancreas; auditory evoked potential; average evok... |
| Norplant | Levonorgestrel implants |
|---|---|
| or absence | Presence |
| 125 I | in the presence of |
| (32)P | presence of |
| EO | Endocrine Ophthalmopathy |
| breast implants | Inert sacs filled with silicone or other material, some of which are covered by polyurethane foam, used to augment the female form cosmetically. (12 Dec 1998) |
|---|---|
| carcinomatous implants | Transference of carcinoma cells from a primary tumour to adjacent tissues where growth continues. (05 Mar 2000) |
| cochlear implants | Electronic devices implanted beneath the skin with electrodes to the cochlear nerve to create sound sensation in persons with sensorineural deafness. (12 Dec 1998) |
| molteno implants | Devices implanted to control intraocular pressure by allowing aqueous fluid to drain from the anterior chamber. The implant was named for dr. Anthony molteno, a south african ophthalmologist, now of new zealand. (hoffman, pocket glossary of ophthalmologic terminology, 1989; telephone conversation with dr. Donald abrams, krieger eye institute, baltimore) (12 Dec 1998) |
| prostheses and implants | Artificial substitutes for body parts, and materials inserted into tissue for functional, cosmetic, or therapeutic purposes. Prostheses can be functional, as in the case of artificial arms and legs, or cosmetic, as in the case of an artificial eye. Implants, all surgically inserted or grafted into the body, tend to be used therapeutically. Implants, experimental is available for those used experimentally. (12 Dec 1998) |
| dental implants | Biocompatible materials placed into (endosseous) or onto (subperiosteal) the jawbone to support a crown, bridge, or artificial tooth, or to stabilise a diseased tooth. (12 Dec 1998) |
| dental implants, single-tooth | Devices, usually alloplastic, surgically inserted into or onto the jawbone, which support a single prosthetic tooth and serve either as abutments or as cosmetic replacements for missing teeth. (12 Dec 1998) |
| drug implants | Small containers or pellets of a solid drug implanted in the body to achieve sustained release of the drug. (12 Dec 1998) |
| implants, experimental | Artificial substitutes for body parts and materials inserted into organisms during experimental studies. (12 Dec 1998) |
| endometrial implants | Fragments of endometrial mucosa implanted on pelvic structure following retrograde transference through the oviducts. (05 Mar 2000) |
| bone diseases, endocrine | Diseases of the bones related to hyperfunction or hypofunction of the endocrine glands. (12 Dec 1998) |
| multiple endocrine adenomatosis | The presence of functioning tumours in more than one endocrine gland, commonly the pancreatic islets and parathyroid glands, which may be associated with Zollinger-Ellison syndrome; dominant inheritance. Synonym: multiple endocrine adenomatosis. (05 Mar 2000) |
| multiple endocrine deficiency syndrome | <syndrome> Acquired deficiency of the function of several endocrine glands, usually on an auto-immune basis. Synonym: multiple glandular deficiency syndrome. (05 Mar 2000) |
| multiple endocrine neoplasia | (type I) This is a hereditary disorder in which two or more of the following glands: parathyroid, pancreas, pituitary, adrenals or thyroid develop hyperplasia or a tumour. (type II) This is a hereditary disorder in which two or more of the following glands: thyroid, adrenal or parathyroid, develop overgrowth (hyperplasia) or malignant cells (cancer). The underlying cause is genetic and a positive family history for this illness is a risk factor. Incidence: approximately 3 in 100,000 people in the general population. Origin: Gr. Plassein = to form (27 Sep 1997) |
| multiple endocrine neoplasia 1 | <radiology> Multiple endrocrine neoplasia syndrome three P's. Pituitary adenoma, 65% can develop Cushing's, acromegaly, prolactinoma, parathyroid hyperplasia / adenoma, 88% can develop hyper-PTH pancreatic isleT-cell tumour, gastrinoma (Z-E) most common, 50% of Z-E can develop MEN-1, inconstant features: bronchial/intestinal carcinoid, thyroid adenoma, adrenal cortical tumour, lipoma, thymoma tissue expression Primary hyperparathyroidism (90%), Gastrinoma (30%), Prolactinoma (15%), Other (10%). Synonym: Wermer syndrome (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|